Indication
Adult patients with chronic sialorrhoea due to neurological conditions.

Medicine details

Medicine name:
clostridium botulinum neurotoxin type A (Xeomin)
SMC ID:
SMC2212
Pharmaceutical company
Merz Pharma UK Ltd
BNF chapter
Central nervous system
Submission type
Full
Status
Publication due date:
11 November 2019
SMC meeting date:
01 October 2019
Patient group submission deadline:
02 September 2019